Pharmacology
COVID-19

Yes to the vaccine
On January 18, FAPESP started the #vacinasim (“yesvaccine”) social media campaign to reinforce public confidence in their safety and effectiveness
By Redação
COVID-19

Distribution challenges
Governments need to work with pharmaceutical and logistics companies to overcome obstacles to start the SARS-CoV-2 immunization campaign
By Tiago Jokura
COVID-19

Butantan develops serum for the novel coronavirus
The Butantan Institute has completed development of a serum to combat SARS-CoV-2
By Redação
COVID-19

Unequal access
Even before efficacy data for the vaccine candidates was released, it was clear that there will not be enough supply to immunize the entire global population before the end of next year
By Redação
COVID-19

Australia gives up on vaccine candidate
A vaccine being developed by the University of Queensland and biotechnology company CSL, both from Australia, is the first of more than 200 candidates to be discarded
By Redação
COVID-19

Vaccines and sharks
A compound extracted from the livers of sharks is used in five coronavirus vaccine candidates
By Redação
FIOCRUZ – 120 YEARS

A continuum of challenges
From the bubonic plague to Zika fever, the Oswaldo Cruz Foundation’s 120-year history has been punctuated by a succession of novel diseases and related discoveries
By Suzel Tunes
FIOCRUZ – 120 YEARS

No rest on the anniversary
FIOCRUZ celebrates 120 years of public health literature, research, assistance, and teaching
By Suzel Tunes
COVID-19

Nasal spray prevents infection in ferrets
A nasal spray tested on ferrets prevented absorption of SARS-CoV-2 and for a period of 24 hours, prevented them from becoming infected with the novel coronavirus when exposed to animals known to be affected by the pathogen
By Redação
COVID-19

Study determines Chinese vaccine is safe
CoronaVac is safe and has no serious side effects
By Redação
COVID-19

Antibody treatment reduces time spent in hospital
American pharmaceutical company Eli Lilly presented the initial results of a clinical trial that used monoclonal antibodies in patients infected with the novel coronavirus
By Redação
Pharmacology

Schistosomiasis medicine
The US FDA has granted orphan drug status to the immunomodulator P-MAPA for use against schistosomiasis
By Redação
COVID-19

Intranasal coronavirus vaccine
Two international studies have suggested that COVID-19 aerosol vaccine candidates, administered intranasally, offer protection against SARS-CoV-2 infection in animals
By Redação
COVID-19

Vaccine tests advance
One of the best-known COVID-19 vaccine candidates achieved good results in the first phase of clinical trials
By Redação
Pharmacology

Lasting action against HIV
Researchers at American pharmaceutical company Gilead Sciences have published the results of clinical trials of a new long-acting antiretroviral against HIV
By Redação
Data

At least 125 COVID-19 vaccines are in development, with 10 already undergoing clinical trials
Vaccines in the clinical trials phase worldwide and in development in Brazil (as of May 27, 2020)
By Redação
Pharmacology

Monkeys are the best animal model
Monkeys appear to be the best animals for testing SARS-CoV-2 vaccines and drugs
By Redação
Video

Techniques in the search for a vaccine against Covid-19
Teams from several countries head projects seeking to produce imunizing agents in a short time
By Redação